LINC00578 as a prognostic biomarker in lung adenocarcinoma via regulation of miR-153-5p
The International Journal of Biological Markers · 02.03.2026
DOI: 10.1177/03936155261417698 ↗Kurz gefasst
Fachartikel in der Zeitschrift The International Journal of Biological Markers, online erschienen am 02.03.2026. Verfasst von Wenju Pan und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Jinling Hospital, The Affiliated Hospital of Medical School, Nanjing University, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Lung adenocarcinoma (LUAD) remains one of the leading causes of cancer-related deaths worldwide, with limited therapeutic efficacy despite advances in treatment. Our study investigated the role of LINC00578 and its regulatory interaction with miR-153-5p in LUAD progression.
Methods
The expression levels of LINC00578 and miR-153-5p were assessed in LUAD tissues and adjacent normal tissues using quantitative real-time polymerase chain reaction. Associations between LINC00578 expression and clinicopathological features and patient prognosis were analyzed. Luciferase reporter assays, proliferation, migration, invasion, and apoptosis analyses, were conducted in LUAD cell lines (PC-9 and H1299) following modulation of LINC00578 and miR-153-5p expression.
Results
LINC00578 was significantly upregulated in LUAD tissues compared to adjacent normal tissues, whereas miR-153-5p was markedly downregulated. High LINC00578 expression was associated with lymph node metastasis, tumor-node-metastasis stage, and poor overall survival. Functional studies revealed that silencing LINC00578 inhibited LUAD cell proliferation, migration, and invasion while promoting apoptosis. Mechanistically, LINC00578 exerted its oncogenic effects by negatively regulating miR-153-5p expression. Inhibition of miR-153-5p reversed the tumor-suppressive effects induced by LINC00578 knockdown.
Conclusion
LINC00578 functions as an oncogenic long non-coding RNA in LUAD by promoting proliferation and metastasis through suppression of miR-153-5p. LINC00578 may serve as a novel prognostic biomarker for LUAD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Jinling Hospital, The Affiliated Hospital of Medical School, Nanjing University, China.
ORCID-Profile: Yaoman Guo
Zitieren
APA
Pan, W., Hong, J., Zhang, M., Wang, S., Lu, X., Ji, T., Zhang, J., & Guo, Y. (2026). LINC00578 as a prognostic biomarker in lung adenocarcinoma via regulation of miR-153-5p. The International Journal of Biological Markers. https://doi.org/10.1177/03936155261417698
Vancouver
Pan W, Hong J, Zhang M, Wang S, Lu X, Ji T, et al. LINC00578 as a prognostic biomarker in lung adenocarcinoma via regulation of miR-153-5p. The International Journal of Biological Markers. 2026. doi:10.1177/03936155261417698
BibTeX
@article{Pan2026,
author = {Pan, Wenju and Hong, Jun and Zhang, Mingwei and Wang, Sumeng and Lu, Xin and Ji, Tingting and Zhang, Jing and Guo, Yaoman},
title = {LINC00578 as a prognostic biomarker in lung adenocarcinoma via regulation of miR-153-5p},
journal = {The International Journal of Biological Markers},
year = {2026},
doi = {10.1177/03936155261417698}
}
EUVIMED